ask="N/A"
ask_size="N/A"
average_daily_volume="513911"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.01"
change_from_200_day_moving_average="3.91"
change_from_50_day_moving_average="2.32"
change_from_52_week_high="-5.88"
change_From_52_week_low="20.17"
change_in_percent="+0.03%"
close="33.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="33.28"
high_52_weeks="38.92"
last_trade_date="1/12/2017"
last_trade_price="33.04"
last_trade_size="19073"
last_trade_time="4:00pm"
low="32.08"
low_52_weeks="12.87"
market_capitalization="1.72B"
moving_average_200_day="29.13"
moving_average_50_day="30.72"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="32.71"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+13.41%"
percent_change_from_50_day_moving_average="+7.56%"
percent_change_from_52_week_high="-15.11%"
percent_change_from_52_week_low="+156.72%"
previous_close="33.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.33"
price_per_sales="36.62"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="13.10"
stock_exchange="NGM"
symbol="TBPH"
volume="232084"
weeks_range_52="12.87 - 38.92"
